znt8 type 2 diabetes

Loss-of-function mutations protective against human disease provide in vivo validation of therapeutic targets 1, 2, 3, but none have yet been described for type 2. The zinc transporter 8 (znt8) action group: the znt8 in type 1 and type 2 diabetes etiology and pathogenesis. The diabetes-susceptible gene slc30a8/znt8 regulates hepatic to type 2 diabetes. precise role of znt8 in increased susceptibility to type 2.

src="https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tWf00yfrxnb87IUbR8_YKg8qHy7V2KzP9jMVpOz1LRTuXbafOoGNfQS9J2Lp42NWYmscYYeBOarzJnWIfMpIioXUbRWkAkm3xOKrrvQm0FSusp5_3EnC6YwQkCWQq1IBb5tgUUkdI7Y0wolBfBKyoiT7KtXbw=s0-d" title="Type 2 Diabetes: Discovery of Rare Gene Mutation Could Create Anti ..." width="80%">

Anti-znt8 (zinc transporter 8) elisa

Znt8 burst onto the scene in 2007 as a promising diabetes target, and follow-up studies suggested that stimulating the zinc transporter protein could have therapeutic. 1. genet mol res. 2012 may 24;11(2):1592-8. doi: 10.4238/2012.may.24.1. slc30a8 (znt8) variations and type 2 diabetes in the chinese han population.. Eiji kawasaki 1) 1) department of metabolism/diabetes and clinical nutrition, nagasaki university hospital, nagasaki 852-8501, japan.

Related Posts by Categories